Home › NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone
 

Keywords :   


NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone

2015-11-18 20:49:12| Agriculture - Topix.net

Australian biopharmaceutical Company Immuron Limited is pleased to announce that the Company's Phase IIb, the IMM-124E clinical trial for the treatment of NASH , has successfully passed its 25% recruitment milestone with 35 patients having been successfully randomized into either arms. Immuron continues to drive its NASH clinical trial recruitment to meet its enrollment goal of 120 biopsy-proven NASH subjects by June 2016.

Tags: patient clinical trail recruitment

Category:Agriculture and Forestry

Latest from this category

All news
09.05Demand, crop prospects, global geopolitics: What's ahead?
09.05Preparing cattle producers for foreign diseases such as FMD
09.05Nebraska Extensions Herd That! conference in North Platte to focus on beef cattle reproduction
09.05U.S. Roundtable for Sustainable Beef elects new leadership and board of directors
09.05Connect, engage at the worlds largest pork-specific trade show
09.05American, Australian cattle producers commit to partnership
09.05Paul Engler passes at age 94
09.05New legislation would support wildlife habitat on private lands
Agriculture and Forestry »
10.05Argentines strike against spending cuts
10.05Two Daytona Waste Pro Drivers Jump into Action After Car Crash
10.05Together for Safer Roads and National Waste & Recycling Association Announce New Participants in FOCUS on Fleet Safety Training
10.05Start Your Day with Tom Gratz, Sales Manager USA, Hitachi Zosen Inova
10.05Scotlands Road to Circularity and Its Water Utilitys Sustainability Story
10.05Simplified Environmental Solutions (SES) Expands Zero Waste to Landfill Operations to Salt Lake City and Kansas City
10.05Zero Waste Lunch at WasteExpo Showcases Potential of Leftover, Undesirable Foods
10.05Rubicon Announces Sale of Fleet Technology Business Unit
More »